NAMI Pharma Marketing Blog Grassley
View PDF of blog article here
Similar Posts
Drug Regulators Are Trying to Quash Study, Senator Says
THE NEW YORK TIMES February 12, 2005 Drug Regulators Are Trying to Quash Study, Senator Says By GARDINER HARRIS WASHINGTON, Feb. 11 – The tension and intrigue surrounding a crucial federal drug advisory committee meeting next week, already high, reached a boil on Friday when Senator Charles E. Grassley charged…
Guidant Didn’t Disclose a Flaw in Defibrillator for 3 Years – NYT / FDA Wrong on Crestor Safety
Guidant Didn’t Disclose a Flaw in Defibrillator for 3 Years_NYT / FDA Wrong on Crestor Safety Tue, 24 May 2005 The New York Times reports that the maker a a heart defirillator knew for 3 years about a malfunction and failed to inform physicians about It because the company “had…
Harvard Psychiatrists Primed For a Fall
The New York Times reports that Federal prosecutors have issued a subpoena seeking information and all documents including transcripts of their testimony produced in litigation relating to three prominent Harvard researchers…
Sen. Grassley Moves to Block Ghostwriting
Until now, American medicine as a profession has turned a blind eye and deaf ear to ghostwritten journal articles that have corrupted the integrity of the medical literature, displacing science-based medicine with corporate propaganda masquerading as science.
Rebecca Riley’s doctor now the target of a grand jury
The Patriot Ledger reports that Rebecca Riley’s psychiatrist, Dr. Kayoko Kifuji, is under criminal investigation by a grand jury.
FDA Proposals Fail to Ensure Independent Drug Safety Assessment
In essence FDA proposals merely change the seating arrangement on the deck of the sinking Titanic. Eli Lilly announced that it intends to seek FDA approval for a long-lasting injectable form of Zyprexa (taken once a month).